Capecitabine is currently under investigation in numerous clinical trials spanning Phase 1 through Phase 4 to evaluate its therapeutic efficacy across various malignancies, including breast cancer, colorectal cancer, metastatic pancreatic carcinoma, nasopharyngeal carcinoma, and intrahepatic cholangiocarcinoma. Sponsored by pharmaceutical corporations such as Novartis and academic centers like Sun Yat-sen University and Fudan University, these studies explore both novel combination regimens and multi-agent chemotherapies. The protocols vary in recruitment status, encompassing active recruiting, completed, and not yet recruiting trials.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT02598349 | RECRUITING | Pancreatic Cancer |
Proton Collaborative Group |
2016-04 | PHASE2 |
| NCT07591493 | NOT_YET_RECRUITING | Pancreatic Neuroendocrine Tumors (pNET); Pancreatic Neuroendocrine Tumors |
Gustave Roussy, Cancer Campus, Grand Paris |
2026-09 | PHASE3 |
| NCT07745296 | NOT_YET_RECRUITING | Biliary Tract Cancer (BTC) |
UNICANCER |
2027-01-02 | PHASE3 |
| NCT07521605 | NOT_YET_RECRUITING | Rectal Cancer Patients |
Guangdong Provincial People's Hospital |
2026-05-20 | PHASE2 |
| NCT07248670 | ACTIVE_NOT_RECRUITING | Nasopharyngeal Cancinoma (NPC) |
Chongqing University Cancer Hospital |
2025-10-04 | PHASE3 |
| NCT06134375 | RECRUITING | Triple Negative Breast Cancer; Residual Disease |
Dartmouth-Hitchcock Medical Center |
2024-11-26 | PHASE1; PHASE2 |
| NCT07590024 | RECRUITING | Nasopharyngeal Carcinoma (NPC) |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2026-05-01 | PHASE3 |
| NCT06393374 | RECRUITING | Triple-Negative Breast Cancer |
Merck Sharp & Dohme LLC |
2024-06-24 | PHASE3 |
| NCT07679360 | NOT_YET_RECRUITING | Triple Negative Breast Cancer |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
2026-07 | PHASE3 |
| NCT06958328 | RECRUITING | Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma; Stage II Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8 |
NRG Oncology |
2025-08-21 | PHASE3 |
| NCT07580339 | NOT_YET_RECRUITING | Rectal Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2026-10 | PHASE2 |
| NCT07118527 | RECRUITING | Patients With Unresectable Locally Advanced or Metastatic Untreated Gastric or Gastroesophageal Junction Adenocarcinoma |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
2025-08-18 | PHASE3 |
| NCT03424005 | RECRUITING | Metastatic Breast Cancer |
Hoffmann-La Roche |
2018-03-30 | PHASE1; PHASE2 |
| NCT07791758 | NOT_YET_RECRUITING | Metastatic Colorectal Carcinoma |
Nanjing Leads Biolabs Co.,Ltd |
2026-09-04 | PHASE1; PHASE2 |
| NCT04495088 | RECRUITING | Rectal Cancer |
Ralf Hofheinz |
2020-09-30 | PHASE3 |
| NCT07021261 | NOT_YET_RECRUITING | Breast Cancer; TNBC |
Fudan University |
2025-06-16 | PHASE3 |
| NCT07686796 | NOT_YET_RECRUITING | Local Advanced Rectal Cancer; PD-1 Inhibitor; PCSK9 Inhibitor; RCT; Radiotherapy; Capecitabine; Oxaliplatin |
Guangdong Provincial People's Hospital |
2027-01-01 | PHASE3 |
| NCT07283367 | RECRUITING | CRC |
Hansoh BioMedical R&D Company |
2025-12-22 | PHASE1; PHASE2 |
| NCT07251062 | NOT_YET_RECRUITING | Esophageal Squamous Cell Carcinoma |
CSPC Megalith Biopharmaceutical Co.,Ltd. |
2025-12-30 | PHASE2; PHASE3 |
| NCT07222215 | RECRUITING | Estrogen-receptor-positive Breast Cancer; Metastatic Breast Cancer; Breast Cancer; Hormone Receptor Positive Breast Cancer; Human Epidermal Growth Factor 2 Negative Carcinoma of Breast; HER2- Breast Cancer; ESR1 Gene Mutation; ER Wildtype; Breast Neoplasms |
Kristina A. Fanucci |
2026-01-16 | PHASE2 |
| NCT05462613 | RECRUITING | Metastatic Colorectal Cancer |
Centre Hospitalier Universitaire de Besancon |
2023-05-09 | PHASE2; PHASE3 |
| NCT06245889 | RECRUITING | Triple Negative Breast Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2024-05-01 | PHASE2 |
| NCT07417241 | NOT_YET_RECRUITING | Breast Cancer; HER2-positive Breast Cancer |
Peking University Cancer Hospital & Institute |
2026-03-31 | PHASE2 |
| NCT07584135 | RECRUITING | Gastric Adenocarcinoma |
NingBo Junyan Hongshi Biosciences Co., Ltd |
2026-05-28 | PHASE3 |
| NCT06829199 | WITHDRAWN | Early Triple Negative Breast Cancer |
Merck Sharp & Dohme LLC |
2025-03-26 | PHASE2 |
| NCT07483060 | NOT_YET_RECRUITING | Rectal Cancer |
Vastra Gotaland Region |
2026-03-12 | PHASE4 |
| NCT07622797 | RECRUITING | Late-stage Resectable Esophageal Squamous Carcinoma |
The First Affiliated Hospital of Henan University of Science and Technology |
2025-11-21 | PHASE2 |
| NCT06963502 | NOT_YET_RECRUITING | Advanced Solid Tumors; Colorectal Cancer; Non-Small Cell Lung Cancer |
Jiangsu Hansoh Pharmaceutical Co., Ltd. |
2025-05-30 | PHASE1 |
| NCT07790445 | NOT_YET_RECRUITING | Malignant Biliary Tract Tumors |
Zhai Wenlong |
2026-07-30 | PHASE4 |
| NCT05288777 | RECRUITING | Breast Cancer; Breast Cancer Stage I; Breast Cancer Stage II; Breast Cancer Stage III |
University of Virginia |
2022-07-11 | PHASE2; PHASE3 |
| NCT07606599 | RECRUITING | Biliary Tract Cancer |
Sichuan Baili Pharmaceutical Co., Ltd. |
2026-07-07 | PHASE3 |
| NCT07284992 | RECRUITING | Rectal Cancer; Advanced Stage Colorectal Cancer; Radiotherapy |
Shandong Provincial Hospital |
2025-09-12 | PHASE2 |
| NCT06093061 | RECRUITING | Nasopharyngeal Carcinoma |
National Cancer Centre, Singapore |
2024-07-03 | PHASE2 |
| NCT07716449 | NOT_YET_RECRUITING | Gastric or Gastroesophageal Junction Adenocarcinoma |
Qilu Pharmaceutical Co., Ltd. |
2026-08 | PHASE3 |
| NCT06561763 | NOT_YET_RECRUITING | High Risk Locally Advanced Nasopharyngeal Carcinoma |
Sun Yat-sen University |
2024-08-20 | PHASE3 |
| NCT07019337 | NOT_YET_RECRUITING | HER2-positive Breast Cancer; Metastatic Breast Cancer |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2025-06-30 | PHASE2 |
| NCT07243938 | NOT_YET_RECRUITING | Locally Advanced Rectal Cancer (LARC); Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma; Metastatic Colorectal Cancer (mCRC); Neoadjuvant Therapy |
Tao Zhang |
2026-01-15 | PHASE2 |
| NCT07381777 | NOT_YET_RECRUITING | Locally Advanced Rectal Cancer (LARC) |
Gruppo Oncologico Italiano di Ricerca Clinica |
2026-01-31 | PHASE2 |
| NCT01935778 | RECRUITING | Gastric Cancer, Adjuvant Chemotherapy, XO |
Asan Medical Center |
2013-10-02 | PHASE3 |
| NCT06992882 | RECRUITING | HER2-positive Breast Cancer |
Fudan University |
2025-07-08 | PHASE3 |
| NCT06105684 | RECRUITING | Metastatic Breast Cancer |
University of Alabama at Birmingham |
2025-02-14 | PHASE2 |
| NCT05365581 | RECRUITING | Gastric Adenocarcinoma; Gastroesophageal Junction (GEJ) Adenocarcinoma; Pancreatic Adenocarcinoma |
Astellas Pharma Global Development, Inc. |
2022-06-07 | PHASE1 |
| NCT06944496 | NOT_YET_RECRUITING | Gastric Carcinoma |
RemeGen Co., Ltd. |
2025-05-15 | PHASE3 |
| NCT06926868 | RECRUITING | Breast Neoplasms |
Bristol-Myers Squibb |
2025-09-11 | PHASE2; PHASE3 |
| NCT06888843 | RECRUITING | Colorectal Cancer |
Nizhny Novgorod Regional Clinical Oncology Center |
2025-02-01 | PHASE2 |
| NCT07652242 | RECRUITING | Triple Negative Breast Cancer (TNBC) |
Immunomic Therapeutics, Inc. |
2026-06 | PHASE1 |
| NCT06771622 | ACTIVE_NOT_RECRUITING | Solid Cancer |
FBD Biologics Limited |
2025-03-13 | PHASE1; PHASE2 |
| NCT07113275 | RECRUITING | Rectal Cancer; Total Neoadjuvant Therapy; Radiotherapy; Immunotherapy |
Tao Zhang |
2026-05-15 | PHASE3 |
| NCT07494448 | NOT_YET_RECRUITING | HER 2 Positive Advanced Breast Cancer; Breast Cancer |
MedSIR |
2026-07-01 | PHASE1; PHASE2 |
| NCT07490262 | RECRUITING | Hepatocellular Carcinoma (HCC) |
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. |
2026-03-27 | PHASE2; PHASE3 |
| NCT07477743 | RECRUITING | Advanced Solid Tumor Cancer |
HC Biopharma Inc. |
2026-03-17 | PHASE1 |
| NCT07503756 | RECRUITING | Metastatic Colorectal Cancer |
Shanghai Junshi Bioscience Co., Ltd. |
2026-04-25 | PHASE2 |
| NCT05472948 | RECRUITING | Adenocarcinoma of Small Intestine; Appendix Carcinoma; Metastatic |
Sun Yat-sen University |
2023-02-01 | PHASE2 |
| NCT05869227 | ACTIVE_NOT_RECRUITING | Nasopharyngeal Carcinoma; Maintenance Therapy |
XIANG YANQUN |
2023-04-28 | PHASE3 |
| NCT06629597 | ACTIVE_NOT_RECRUITING | Nasopharyngeal Carcinoma |
MediLink Therapeutics (Suzhou) Co., Ltd. |
2024-12-31 | PHASE3 |
| NCT03073785 | ACTIVE_NOT_RECRUITING | Pancreatic Adenocarcinoma; Recurrent Pancreatic Carcinoma; Stage I Pancreatic Cancer AJCC v6 and v7; Stage IA Pancreatic Cancer AJCC v6 and v7; Stage IB Pancreatic Cancer AJCC v6 and v7; Stage II Pancreatic Cancer AJCC v6 and v7; Stage IIA Pancreatic Cancer AJCC v6 and v7; Stage IIB Pancreatic Cancer AJCC v6 and v7; Stage III Pancreatic Cancer AJCC v6 and v7; Stage IV Pancreatic Cancer AJCC v6 and v7 |
University of Nebraska |
2016-09-16 | PHASE2 |
| NCT07768189 | NOT_YET_RECRUITING | Oropharyngeal Carcinoma (OPC) |
Corbus Pharmaceuticals Inc. |
2026-09-20 | PHASE3 |
| NCT05702229 | RECRUITING | Gastric Cancer |
AstraZeneca |
2023-01-16 | PHASE2 |
| NCT06780787 | RECRUITING | Rectal Adenocarcinoma; Stage IIA Rectal Cancer AJCC v8; Stage III Rectal Cancer AJCC v8 |
City of Hope Medical Center |
2025-05-20 | PHASE2 |
| NCT07407465 | RECRUITING | Colorectal Cancer; Colorectal Adenocarcinoma; Rectal Adenocarcinoma; Rectal Cancer, Adenocarcinoma; Rectal Cancer, Metastatic; Colon Cancer Metastatic; Colon Cancer Adenocarcinoma |
Gruppo Oncologico del Nord-Ovest |
2025-10-20 | PHASE2 |
| NCT06544655 | ACTIVE_NOT_RECRUITING | Advanced Solid Tumors |
Bristol-Myers Squibb |
2024-10-10 | PHASE1 |
| NCT05062889 | SUSPENDED | Stage II Colon Cancer; Stage III Colon Cancer; HER2-positive Colon Cancer; RAS Wild-type Colon Cancer |
Gruppo Oncologico del Nord-Ovest |
2023-05-17 | PHASE2 |
| NCT06578052 | RECRUITING | Pancreatic Cancer |
Junjie Hang |
2024-08-28 | |
| NCT06790212 | NOT_YET_RECRUITING | Colon Cancer |
Sun Yat-sen University |
2025-04-28 | PHASE2 |
| NCT02945566 | ACTIVE_NOT_RECRUITING | Adenocarcinoma of the Rectum |
University of Birmingham |
2017-06-14 | PHASE2; PHASE3 |
| NCT06312176 | RECRUITING | Breast Neoplasms |
Merck Sharp & Dohme LLC |
2024-04-14 | PHASE3 |
| NCT07071337 | RECRUITING | Metastatic Breast Cancer |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
2025-07-18 | PHASE3 |
| NCT06942234 | RECRUITING | Inoperable Locally Advanced HER2-Negative Breast Cancer; Metastatic HER2-Negative Breast Cancer |
Jiangsu Alphamab Biopharmaceuticals Co., Ltd |
2025-06-01 | PHASE1; PHASE2 |
| NCT05803382 | RECRUITING | Metastatic Colorectal Carcinoma; Metastatic Malignant Solid Neoplasm; Stage IV Colorectal Cancer AJCC v8; Unresectable Colorectal Carcinoma; Unresectable Malignant Solid Neoplasm |
National Cancer Institute (NCI) |
2023-11-08 | PHASE1 |
| NCT04919226 | ACTIVE_NOT_RECRUITING | Neuroendocrine Tumors |
ITM Solucin GmbH |
2021-12-21 | PHASE3 |
| NCT07570914 | NOT_YET_RECRUITING | Colorectal Cancer Liver Metastases (CRLM); Colorectal Cancer; Liver Metastasis |
Tianjin Medical University Cancer Institute and Hospital |
2026-05-30 | PHASE2 |
| NCT07462143 | RECRUITING | Colorectal (Colon or Rectal) Cancer |
RemeGen Co., Ltd. |
2026-05-12 | PHASE2; PHASE3 |
| NCT05794750 | NOT_YET_RECRUITING | Locally Advanced Rectal Cancer |
JIN JING |
2023-04-24 | PHASE2 |
| NCT04808323 | RECRUITING | Rectal Adenocarcinoma |
Medical College of Wisconsin |
2021-06-17 | PHASE1 |
| NCT06247995 | ACTIVE_NOT_RECRUITING | Breast Cancer |
Novartis Pharmaceuticals |
2024-08-14 | PHASE1; PHASE2 |
| NCT06888674 | NOT_YET_RECRUITING | Pancreatic Cancer Resectable |
Zhejiang University |
2025-04-01 | PHASE1; PHASE2 |
| NCT06761417 | RECRUITING | Solid Tumors; Children; Adolescents |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2025-01-24 | PHASE2 |
| NCT06239727 | RECRUITING | Nasopharyngeal Carcinoma |
Sun Yat-sen University |
2024-03-01 | PHASE3 |
| NCT07229846 | NOT_YET_RECRUITING | Colorectal Cancer |
Yanqiao Zhang |
2026-02 | PHASE2 |
| NCT06759090 | NOT_YET_RECRUITING | Metastatic Pancreatic Carcinoma |
Zhejiang University |
2025-01-15 | PHASE2 |
| NCT05800275 | RECRUITING | Leptomeningeal Metastasis; Leptomeningeal Disease; HER2-positive Metastatic Breast Cancer |
UNICANCER |
2023-12-18 | PHASE2 |
| NCT06202261 | RECRUITING | Metastatic Breast Cancer; Recurrent Breast Cancer; Advanced Malignancies |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2023-04-13 | PHASE1; PHASE2 |
| NCT06648785 | ENROLLING_BY_INVITATION | GI Cancers |
University of Vermont Medical Center |
2024-10-21 | PHASE2 |
| NCT06374888 | NOT_YET_RECRUITING | Her2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis |
Convalife (Shanghai) Co., Ltd. |
2024-04-30 | PHASE2 |
| NCT06776770 | RECRUITING | Gastric Cancer |
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center |
2024-08-03 | PHASE1; PHASE2 |
| NCT04246684 | ACTIVE_NOT_RECRUITING | Rectal Cancer Stage III |
Prof. Dr. med. Claus Rödel |
2020-11-05 | PHASE3 |
| NCT04965064 | RECRUITING | Breast Cancer |
University of Rochester |
2022-09-23 | PHASE2 |
| NCT06568692 | RECRUITING | Breast Cancer; TNBC - Triple-Negative Breast Cancer; HER2-negative Breast Cancer |
Processa Pharmaceuticals |
2024-10-02 | PHASE2 |
| NCT07067268 | RECRUITING | Nasopharyngeal Cancinoma (NPC) |
Fudan University |
2024-09-14 | PHASE2 |
| NCT03257163 | ACTIVE_NOT_RECRUITING | Epstein-Barr Virus Positive; Gastric Adenocarcinoma; Mismatch Repair Protein Deficiency; Stage IB Gastric Cancer AJCC v7; Stage II Gastric Cancer AJCC v7; Stage IIA Gastric Cancer AJCC v7; Stage IIB Gastric Cancer AJCC v7; Stage III Gastric Cancer AJCC v7; Stage IIIA Gastric Cancer AJCC v7; Stage IIIB Gastric Cancer AJCC v7; Stage IIIC Gastric Cancer AJCC v7 |
Rutgers, The State University of New Jersey |
2017-09-29 | PHASE2 |
| NCT05902533 | ACTIVE_NOT_RECRUITING | Anal Cancer |
University of Cincinnati |
2023-08-14 | PHASE2; PHASE3 |
| NCT06494995 | RECRUITING | Head and Neck Squamous Cell Carcinoma |
Fudan University |
2024-07-03 | PHASE2 |
| NCT06884670 | COMPLETED | Rectal Cancer |
The First Affiliated Hospital with Nanjing Medical University |
2024-08-18 | PHASE2 |
| NCT06639178 | RECRUITING | Breast Cancer |
Centro di Riferimento Oncologico - Aviano |
2024-08-01 | |
| NCT06507371 | ACTIVE_NOT_RECRUITING | Rectal Cancer |
Sir Run Run Shaw Hospital |
2024-07-29 | PHASE3 |
| NCT06405139 | RECRUITING | Colorectal Cancer |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2024-05-01 | PHASE2 |
| NCT04895358 | ACTIVE_NOT_RECRUITING | Breast Neoplasms |
Merck Sharp & Dohme LLC |
2021-06-18 | PHASE3 |
| NCT05836584 | ACTIVE_NOT_RECRUITING | Clinical Stage I Gastric Cancer AJCC v8; Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage II Gastric Cancer AJCC v8; Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma |
National Cancer Institute (NCI) |
2023-12-06 | PHASE2 |
| NCT06382142 | ACTIVE_NOT_RECRUITING | Triple-Negative Breast Cancer |
Sichuan Baili Pharmaceutical Co., Ltd. |
2024-06-21 | PHASE3 |
| NCT06463548 | NOT_YET_RECRUITING | Biliary Tract Carcinoma |
Yunpeng Liu |
2024-07-01 | |
| NCT07117435 | RECRUITING | Colorectal Liver Metastases; First-line Treatment |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
2025-05-13 | PHASE1 |
| NCT02170090 | ACTIVE_NOT_RECRUITING | Cholangiocarcinoma; Gall Bladder Carcinoma |
Universitätsklinikum Hamburg-Eppendorf |
2014-04 | PHASE3 |
| NCT06192680 | NOT_YET_RECRUITING | Colorectal Cancer |
Harbin Medical University |
2024-04-01 | PHASE2 |
| NCT04649385 | COMPLETED | Advanced Solid Tumor |
BeiGene |
2021-03-04 | PHASE1 |
| NCT05042791 | UNKNOWN | HER2-positive Metastatic Breast Cancer |
Jiangxi Provincial Cancer Hospital |
2022-03-01 | PHASE2 |
| NCT06023758 | RECRUITING | HER2-positive Locally Advanced Resectable Gastric Cancer |
Peking University |
2023-09-22 | PHASE2 |
| NCT05374512 | ACTIVE_NOT_RECRUITING | Breast Cancer |
AstraZeneca |
2022-05-16 | PHASE3 |
| NCT05007106 | COMPLETED | Uterine Cervical Neoplasms; Endometrial Neoplasms; Squamous Cell Carcinoma of Head and Neck; Gallbladder Neoplasms; Cholangiocarcinoma; Esophageal Neoplasms; Triple Negative Breast Neoplasms; Hepatocellular Carcinoma; Urinary Bladder Neoplasms; Ovarian Neoplasms; Stomach Neoplasms |
Merck Sharp & Dohme LLC |
2021-09-16 | PHASE2 |
| NCT05914389 | RECRUITING | Colon Neoplasm |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2023-08 | PHASE2 |
| NCT05807880 | ACTIVE_NOT_RECRUITING | Nasopharyngeal Neoplasms |
Sun Yat-sen University |
2023-09-01 | PHASE2 |
| NCT05980481 | ACTIVE_NOT_RECRUITING | Gastric Cancer |
RemeGen Co., Ltd. |
2023-08-04 | PHASE2; PHASE3 |
| NCT04621370 | UNKNOWN | Rectal Cancer; Rectal Adenocarcinoma; Rectal Neoplasms |
Liz-Anne Lewsley |
2020-12-07 | PHASE2 |
| NCT05479240 | NOT_YET_RECRUITING | Immunotherapy |
Fujian Cancer Hospital |
2023-09-01 | PHASE2 |
| NCT04295317 | ACTIVE_NOT_RECRUITING | Intrahepatic Cholangiocarcinoma |
Shanghai Zhongshan Hospital |
2020-08-01 | PHASE2 |
| NCT03585465 | TERMINATED | Childhood Solid Tumor |
Centre Oscar Lambret |
2019-03-26 | PHASE1; PHASE2 |
| NCT05507112 | ACTIVE_NOT_RECRUITING | Locally Advanced Rectal Cancer |
Peking Union Medical College Hospital |
2022-12-20 | PHASE2 |
| NCT05939726 | COMPLETED | Palmar-Plantar Erythrodysesthesia; Palmar-Plantar Erythrodysesthesia Due to Cytotoxic Therapy |
Sarawak General Hospital |
2023-05-16 | |
| NCT05625412 | COMPLETED | Advanced Solid Tumors |
Bristol-Myers Squibb |
2022-12-09 | PHASE1 |
| NCT05177133 | RECRUITING | Gastric Adenocarcinoma; Esophageal Adenocarcinoma |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2021-11-05 | PHASE2 |
| NCT04263298 | RECRUITING | Metastatic Breast Cancer |
Herui Yao |
2018-05-01 | PHASE3 |
| NCT05965154 | UNKNOWN | Head and Neck Squamous Cell Carcinoma |
Second Affiliated Hospital of Guangzhou Medical University |
2023-08-01 | PHASE2 |
| NCT02931890 | ACTIVE_NOT_RECRUITING | Gastric Cancer |
The Netherlands Cancer Institute |
2017-12-21 | PHASE2 |
| NCT02669173 | COMPLETED | Glioblastoma |
Case Comprehensive Cancer Center |
2016-10-11 | PHASE1 |
| NCT06355024 | COMPLETED | Triple-negative Breast Cancer |
Fudan University |
2024-05-11 | PHASE2 |
| NCT04942626 | COMPLETED | Rectal Cancer |
Goethe University |
2021-08-20 | PHASE1 |
| NCT04787354 | RECRUITING | Gastric Cancer |
Hallym University Medical Center |
2021-11-01 | PHASE3 |
| NCT04371224 | UNKNOWN | Pancreatic Cancer |
Seoul National University Hospital |
2020-06-23 | PHASE2 |
| NCT05845138 | UNKNOWN | Breast Cancer |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
2023-07-25 | PHASE1; PHASE2 |
| NCT06430827 | UNKNOWN | Biliary Tract Carcinoma |
Ba Yi |
2024-06-30 | PHASE2 |
| NCT04844385 | UNKNOWN | Esophageal Squamous Cell Carcinoma |
Sun Yat-sen University |
2021-02-20 | PHASE2 |
| NCT05578287 | UNKNOWN | Colorectal Cancer |
Sun Yat-sen University |
2023-07-18 | PHASE2 |
| NCT04891900 | UNKNOWN | Gastric Cancer; Adenocarcinoma of Esophagogastric Junction |
Henan Cancer Hospital |
2021-05-10 | |
| NCT03011060 | UNKNOWN | Breast Neoplasm Female |
The First Hospital of Jilin University |
2016-12 | PHASE3 |
| NCT04859582 | WITHDRAWN | Stomach Neoplasms |
Merck Sharp & Dohme LLC |
2018-11-08 | PHASE3 |
| NCT02794571 | COMPLETED | Advanced/Metastatic Tumors |
Genentech, Inc. |
2016-05-23 | PHASE1 |
| NCT03921684 | ACTIVE_NOT_RECRUITING | Rectal Cancer |
Baruch Brenner |
2019-04-10 | PHASE2 |
| NCT04134897 | UNKNOWN | Rectal Neoplasms Malignant; Rectum Carcinoma; Rectal Cancer |
Blokhin's Russian Cancer Research Center |
2019-10-14 | PHASE3 |
| NCT05585814 | ACTIVE_NOT_RECRUITING | Locally Advanced Rectal Cancer |
Shanghai Changzheng Hospital |
2023-05-01 | PHASE2 |
| NCT05064085 | COMPLETED | Hormone Receptor-positive Breast Cancer |
H. Lee Moffitt Cancer Center and Research Institute |
2021-10-12 | PHASE1 |
| NCT05964543 | UNKNOWN | Gastroesophageal Junction (GEJ) Adenocarcinoma |
QureBio Ltd. |
2023-06-21 | PHASE1; PHASE2 |
| NCT05415917 | WITHDRAWN | Pancreatic Cancer |
Rutgers, The State University of New Jersey |
2022-07-29 | PHASE2 |
| NCT04259944 | UNKNOWN | Colon Cancer |
IFOM ETS - The AIRC Institute of Molecular Oncology |
2020-06-16 | PHASE2 |
| NCT04922008 | UNKNOWN | Breast Cancer |
Fudan University |
2021-07-01 | PHASE2 |
| NCT03503136 | UNKNOWN | Nasopharyngeal Carcinoma |
Sun Yat-sen University |
2018-06 | PHASE3 |
| NCT04351867 | UNKNOWN | Stomach Neoplasms |
LiNing |
2020-09 | PHASE3 |
| NCT06247995 | Not yet recruiting | Breast Cancer |
Novartis Pharmaceuticals|Novartis |
2024-05-16 | Phase 1|Phase 2 |
| NCT04337658 | UNKNOWN | HER2-positive Breast Cancer |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2020-07-01 | PHASE3 |
| NCT04301557 | UNKNOWN | DMMR Colorectal Cancer; MSI-H Colorectal Cancer; Locally Advanced Colorectal Cancer |
Sun Yat-sen University |
2020-07-31 | PHASE2 |
| NCT05411380 | UNKNOWN | Breast Cancer |
wang shusen |
2022-10-03 | PHASE2 |
| NCT03615326 | COMPLETED | Gastric Neoplasms; Gastroesophageal Junction Adenocarcinoma |
Merck Sharp & Dohme LLC |
2018-10-05 | PHASE3 |
| NCT04882241 | COMPLETED | Gastric Cancer; Gastroesophageal Junction Cancer |
Merck Sharp & Dohme LLC |
2020-07-29 | PHASE3 |
| NCT06246461 | COMPLETED | Capecitabine |
Jingjiang People's Hospital |
2022-01-01 | |
| NCT05608785 | UNKNOWN | Gastric Cancer; Gastroesophageal-junction Cancer |
Henan Cancer Hospital |
2023-01-01 | PHASE1; PHASE2 |
| NCT04782804 | UNKNOWN | Cholangiocarcinoma, Intrahepatic |
Fudan University |
2021-01-01 | PHASE1; PHASE2 |
| NCT05246982 | UNKNOWN | Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) |
Shanghai Henlius Biotech |
2022-03-23 | PHASE2 |
| NCT01972919 | COMPLETED | Unresectable Pancreatic Cancer |
Medical College of Wisconsin |
2015-12-10 | PHASE2 |
| NCT05009069 | ACTIVE_NOT_RECRUITING | Rectal Neoplasms; Rectal Cancer |
Hoffmann-La Roche |
2022-03-18 | PHASE2 |
| NCT04933227 | TERMINATED | Stomach Neoplasms; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma |
Hoffmann-La Roche |
2021-08-06 | PHASE2 |
| NCT03703427 | UNKNOWN | Pathologic Residual Cancer Cells |
Zhiyong Yu |
2018-11 | PHASE2 |
| NCT06085742 | Recruiting | Breast Cancer |
University of Illinois at Chicago |
2023-11-22 | Phase 2 |
| NCT03901339 | COMPLETED | Metastatic Breast Cancer |
Gilead Sciences |
2019-05-08 | PHASE3 |
| NCT05566743 | UNKNOWN | Cancer of Pancreas |
Menoufia University |
2022-09-11 | PHASE2 |
| NCT03153280 | TERMINATED | Colorectal Neoplasms; Stomach Neoplasm; Esophageal Neoplasms |
Cancer Trials Ireland |
2022-01-13 | PHASE1 |
| NCT03676517 | UNKNOWN | Locally Advanced Rectal Cancer |
Yonsei University |
2019-03 | |
| NCT05929885 | Recruiting | Metastatic Pancreatic Cancer |
National Cancer Centre Singapore|National Medical Research Council (NMRC) Singapore |
2023-08-30 | Phase 2 |
| NCT01804790 | COMPLETED | Cancer of the Rectum |
UNICANCER |
2012-01 | PHASE3 |
| NCT04932187 | UNKNOWN | Hepatobiliary, Pancreatic and Other Gastrointestinal Carcinoma (Non-stomach, Non-esophagi) |
Ruijin Hospital |
2021-08-01 | PHASE1 |
| NCT04068103 | ACTIVE_NOT_RECRUITING | Colon Adenocarcinoma; Stage IIA Colon Cancer AJCC v8 |
NRG Oncology |
2019-12-16 | PHASE2; PHASE3 |
| NCT03561740 | RECRUITING | Breast Cancer |
Sun Yat-sen University |
2018-07-25 | PHASE3 |
| NCT03813784 | COMPLETED | Gastric Cancer; GastroEsophageal Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2019-03-07 | PHASE3 |
| NCT04220528 | UNKNOWN | Nasopharyngeal Carcinoma |
Fujian Cancer Hospital |
2019-12-01 | PHASE2 |
| NCT05348278 | UNKNOWN | Hand-Foot Syndrome |
Mahidol University |
2021-12-20 | PHASE2; PHASE3 |
| NCT05216653 | COMPLETED | MSS Locally Advanced Rectal Adenocarcinoma |
Sir Run Run Shaw Hospital |
2022-04-07 | PHASE2 |
| NCT05588297 | UNKNOWN | Colorectal Cancer Liver Metastases |
Shanghai Changzheng Hospital |
2022-10 | PHASE2 |
| NCT03299660 | COMPLETED | Rectal Cancer |
Peter MacCallum Cancer Centre, Australia |
2018-04-30 | PHASE2 |
| NCT04894123 | TERMINATED | Colorectal Adenocarcinoma; Oesogastric |
GERCOR - Multidisciplinary Oncology Cooperative Group |
2022-02-07 | PHASE2 |
| NCT04675983 | TERMINATED | Gastric Adenocarcinoma |
Innovent Biologics (Suzhou) Co. Ltd. |
2021-03-10 | PHASE3 |
| NCT01494662 | COMPLETED | Breast Cancer |
Dana-Farber Cancer Institute |
2012-02 | PHASE2 |
| NCT04406857 | TERMINATED | Locally Advanced Rectal Carcinoma; Rectal Adenocarcinoma; Stage II Rectal Cancer AJCC v8; Stage III Rectal Cancer AJCC v8 |
National Cancer Institute (NCI) |
2021-03-17 | PHASE1 |
| NCT04733963 | UNKNOWN | Colorectal Cancer |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2021-03-01 | PHASE2 |
| NCT04745975 | UNKNOWN | Triple Negative Breast Cancer |
Fudan University |
2021-02-01 | PHASE2 |
| NCT04663763 | UNKNOWN | Locally Advanced Rectal Cancer |
Zhejiang Cancer Hospital |
2020-12-01 | PHASE2 |
| NCT04246502 | UNKNOWN | Metastatic Breast Cancer |
Shandong Cancer Hospital and Institute |
2020-01 | PHASE2 |
| NCT04083365 | UNKNOWN | RECTAL CANCER |
AUSL Romagna Rimini |
2020-01-01 | PHASE2 |
| NCT02973386 | COMPLETED | Local Advanced High Risk Nasopharyngeal Carcinoma |
Sun Yat-sen University |
2017-01-13 | PHASE3 |
| NCT03535727 | COMPLETED | Adenocarcinoma; Pancreatic Neoplasms; Neoplasm, Glandular; Neoplasms; Neoplasms Pancreatic; Digestive System Neoplasm; Endocrine Gland Neoplasms; Digestive System Disease; Pancreatic Diseases; Endocrine System Diseases |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2018-06-21 | PHASE1; PHASE2 |
| NCT04177602 | TERMINATED | Locally Advanced Rectal Cancer |
Universitätsklinikum Hamburg-Eppendorf |
2019-11-04 | PHASE1; PHASE2 |
| NCT04097444 | UNKNOWN | Metastatic Colorectal Cancer |
Chugai Pharmaceutical |
2019-10-11 | PHASE2 |
| NCT04508686 | UNKNOWN | Advanced Cervical Cancer |
Ruijin Hospital |
2020-08-01 | PHASE1 |
| NCT04324476 | UNKNOWN | Advanced Colorectal Cancer |
Jiangsu Cancer Institute & Hospital |
2019-09-01 | PHASE2 |
| NCT03523585 | COMPLETED | Breast Cancer |
Daiichi Sankyo |
2018-08-01 | PHASE3 |
| NCT04250948 | UNKNOWN | Gastric Cancer; Locally Advanced Solid Tumor |
Sun Yat-sen University |
2019-10-12 | PHASE2 |
| NCT04390958 | UNKNOWN | Esophageal Squamous Cell Carcinoma |
Chinese Academy of Medical Sciences |
2020-05-15 | PHASE2 |
| NCT02371304 | UNKNOWN | Rectal Cancer |
Amsterdam UMC, location VUmc |
2015-10 | PHASE3 |
| NCT03970694 | TERMINATED | Colon Cancer |
Sun Yat-sen University |
2019-05-11 | PHASE3 |
| NCT03125980 | RECRUITING | Locally Advanced Colon Cancer |
Fudan University |
2017-05 | PHASE3 |
| NCT04411537 | UNKNOWN | Locally Advanced Rectal Cancer |
Fudan University |
2020-07-01 | PHASE2 |
| NCT02451553 | COMPLETED | Advanced Malignant Solid Neoplasm; Bile Duct Carcinoma; Recurrent Malignant Solid Neoplasm; Recurrent Pancreatic Carcinoma; Stage III Pancreatic Cancer AJCC v6 and v7; Stage IVA Pancreatic Cancer; Stage IVB Pancreatic Cancer |
University of Washington |
2015-11-05 | PHASE1 |
| NCT03839823 | COMPLETED | Breast Cancer |
Novartis Pharmaceuticals |
2019-02-25 | PHASE2 |
| NCT03889626 | UNKNOWN | Stomach Neoplasms; Gastrointestinal Neoplasms; Stomach Diseases; Digestive System Neoplasms; Capecitabine; Apatinib; Neoplasms; Molecular Mechanisms of Pharmacological Action |
Fudan University |
2019-03-22 | PHASE3 |
| NCT02229149 | TERMINATED | Breast Neoplasms; Malignant Tumor of the Breast |
US Oncology Research |
2014-12 | PHASE2 |
| NCT03512756 | TERMINATED | Pancreatic Cancer |
Tyme, Inc |
2018-03-27 | PHASE2; PHASE3 |
| NCT02958111 | UNKNOWN | Nasopharyngeal Carcinoma |
Sun Yat-sen University |
2017-01 | PHASE3 |
| NCT02555358 | COMPLETED | Gastric Cancer |
Qun Zhao |
2014-11 | PHASE2 |
| NCT04833998 | UNKNOWN | Hand-foot Syndrome |
Instituto Brasileiro de Controle do Cancer |
2019-08-02 | PHASE2 |
| NCT03383679 | COMPLETED | Breast Cancer Female; Triple Negative and Androgen Receptor Positive |
UNICANCER |
2018-03-14 | PHASE2 |
| NCT02954055 | COMPLETED | Breast Cancer |
ETOP IBCSG Partners Foundation |
2017-09-13 | PHASE2 |
| NCT02007148 | UNKNOWN | Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma |
International Group of Endovascular Oncology |
2013-11 | PHASE2 |
| NCT03473639 | COMPLETED | Metastatic Breast Cancer; Breast Cancer |
University of Virginia |
2019-01-29 | PHASE1 |
| NCT03376659 | TERMINATED | Metastatic Colorectal Cancer; Colorectal Adenocarcinoma; Pancreatic Adenocarcinoma; Metastatic Pancreatic Cancer |
Georgetown University |
2018-08-08 | PHASE1; PHASE2 |
| NCT02940925 | COMPLETED | Nasopharyngeal Carcinoma |
Sun Yat-sen University |
2016-10-20 | PHASE3 |
| NCT04797923 | UNKNOWN | Advanced Gastric Cancer; Peritoneal Carcinomatosis |
Gangnam Severance Hospital |
2019-12-01 | PHASE2 |
| NCT03501979 | TERMINATED | Metastatic Breast Cancer; Leptomeningeal Disease |
University of Alabama at Birmingham |
2019-02-20 | PHASE2 |
| NCT03322215 | TERMINATED | Breast Cancer Metastatic |
Theodoros Foukakis |
2017-10-24 | PHASE2 |
| NCT02445391 | ACTIVE_NOT_RECRUITING | Estrogen Receptor Negative; HER2/Neu Negative; Invasive Breast Carcinoma; Progesterone Receptor Negative; Stage II Breast Cancer; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage III Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Triple-Negative Breast Carcinoma |
ECOG-ACRIN Cancer Research Group |
2015-10-20 | PHASE3 |
| NCT04296240 | UNKNOWN | Rectal Cancer |
Peking University Cancer Hospital & Institute |
2019-03-01 | PHASE2 |
| NCT04202978 | UNKNOWN | Hepatic Metastasis of Colorectal Cancer |
Zhongshan Hospital Xiamen University |
2020-03-01 | PHASE1; PHASE2 |
| NCT03854799 | COMPLETED | Colon Rectal Cancer |
Gruppo Oncologico del Nord-Ovest |
2019-04-01 | PHASE2 |
| NCT05052437 | COMPLETED | Advanced and Metastatic Breast Cancer |
Beijing Biostar Pharmaceuticals Co., Ltd. |
2020-10-15 | PHASE1 |
| NCT04185649 | UNKNOWN | HER2-positive Advanced Breast Cancer |
Bio-Thera Solutions |
2018-07-01 | PHASE3 |
| NCT04340401 | UNKNOWN | Rectal Cancer |
Peking University Cancer Hospital & Institute |
2020-05-25 | PHASE2 |
| NCT03579758 | WITHDRAWN | Stage I Gallbladder Cancer AJCC v8; Stage II Gallbladder Cancer AJCC v8; Stage IIA Gallbladder Cancer AJCC v8; Stage IIB Gallbladder Cancer AJCC v8; Stage III Gallbladder Cancer AJCC v8; Stage IIIA Gallbladder Cancer AJCC v8; Stage IIIB Gallbladder Cancer AJCC v8 |
Emory University |
2019-04-03 | PHASE3 |
| NCT03729687 | UNKNOWN | Rectal Cancer |
Uppsala University |
2016-07-04 | PHASE2 |
| NCT02368860 | COMPLETED | Pancreatic Cancer |
National Cancer Centre, Singapore |
2013-09-17 | PHASE1 |
| NCT02842125 | TERMINATED | Metastatic Solid Tumor Cancer; Recurrent Head and Neck Cancer |
MultiVir, Inc. |
2018-11-20 | PHASE1; PHASE2 |
| NCT02460419 | COMPLETED | Nasopharyngeal Carcinoma |
Sun Yat-sen University |
2015-04 | PHASE3 |
| NCT02921256 | COMPLETED | Rectal Adenocarcinoma; Stage II Rectal Cancer AJCC v7; Stage III Rectal Cancer AJCC v7 |
National Cancer Institute (NCI) |
2017-01-11 | PHASE2 |
| NCT03129074 | WITHDRAWN | Advanced or Metastatic Biliary Tract Cancer |
ASLAN Pharmaceuticals |
2018-05 | PHASE2 |
| NCT02114359 | COMPLETED | Gastric Cancer |
Seoul National University Hospital |
2014-02 | PHASE3 |
| NCT03598348 | UNKNOWN | Gastric Cancer |
Huazhong University of Science and Technology |
2018-01-16 | PHASE3 |
| NCT03300609 | TERMINATED | Colorectal Adenocarcinoma; RAS Wild Type; Stage III Colorectal Cancer AJCC v7; Stage IIIA Colorectal Cancer AJCC v7; Stage IIIB Colorectal Cancer AJCC v7; Stage IIIC Colorectal Cancer AJCC v7; Stage IV Colorectal Cancer AJCC v7; Stage IVA Colorectal Cancer AJCC v7; Stage IVB Colorectal Cancer AJCC v7 |
University of Southern California |
2018-02-27 | PHASE3 |
| NCT03279601 | UNKNOWN | Neuroendocrine Tumors |
Peking University |
2017-09-01 | PHASE2 |
| NCT02734290 | ACTIVE_NOT_RECRUITING | Triple Negative Breast Cancer |
Providence Health & Services |
2016-02-23 | PHASE1; PHASE2 |
| NCT02177552 | UNKNOWN | Esophageal Neoplasms; Stomach Neoplasms |
Rigshospitalet, Denmark |
2014-06 | PHASE2 |
| NCT03231176 | COMPLETED | Biliary Tract Cancer |
ASLAN Pharmaceuticals |
2017-12-19 | PHASE2 |
| NCT03117855 | WITHDRAWN | Bile Duct Adenocarcinoma; Stage III Intrahepatic Cholangiocarcinoma; Stage IVA Intrahepatic Cholangiocarcinoma; Stage IVB Intrahepatic Cholangiocarcinoma |
City of Hope Medical Center |
2016-12 | PHASE1 |
| NCT03578874 | COMPLETED | Hepatocellular Carcinoma |
The University of Hong Kong |
2016-06-20 | PHASE2 |
| NCT03469557 | COMPLETED | Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma |
BeiGene |
2017-07-18 | PHASE2 |
| NCT02494583 | COMPLETED | Gastric Adenocarcinoma |
Merck Sharp & Dohme LLC |
2015-07-31 | PHASE3 |
| NCT03114085 | UNKNOWN | Hepatocellular Carcinoma |
First Affiliated Hospital of Guangxi Medical University |
2017-05-20 | PHASE2 |
| NCT01077427 | UNKNOWN | Resected Pancreatic Adenocarcinoma |
Klinikum der Universitaet Muenchen, Grosshadern |
2012-03 | PHASE3 |
| NCT02726399 | TERMINATED | Gastric Cancer; Gastroesophageal Junction Cancer |
Memorial Sloan Kettering Cancer Center |
2016-03-18 | PHASE2 |
| NCT03197584 | WITHDRAWN | Ovarian Cancer |
ImmunityBio, Inc. |
2017-12 | PHASE1; PHASE2 |
| NCT03167177 | WITHDRAWN | Melanoma |
ImmunityBio, Inc. |
2017-12 | PHASE1; PHASE2 |
| NCT03169777 | WITHDRAWN | Colorectal Cancer |
ImmunityBio, Inc. |
2018-08 | PHASE1; PHASE2 |
| NCT03381352 | UNKNOWN | Anal Cancer |
Chinese Academy of Medical Sciences |
2015-12-02 | PHASE2 |
| NCT02688023 | UNKNOWN | Colorectal Cancer |
Chinese Academy of Medical Sciences |
2014-03 | PHASE2 |
| NCT03086785 | UNKNOWN | Breast Cancer Metastatic |
Hebei Medical University Fourth Hospital |
2016-11-24 | PHASE2 |
| NCT02716766 | COMPLETED | Carcinoma, Hepatocellular; Secondary |
The University of Hong Kong |
2016-03 | PHASE2 |
| NCT02767752 | TERMINATED | Pancreatic Cancer |
Herlev Hospital |
2016-11 | PHASE2 |
| NCT02854072 | UNKNOWN | Pancreatic Cancer |
Samsung Pharmaceutical Co., Ltd. |
2015-11 | PHASE3 |
| NCT01516944 | COMPLETED | Gastric Cancer |
Hebei Medical University |
2012-02 | PHASE2; PHASE3 |
| NCT01821729 | COMPLETED | Pancreatic Cancer |
Massachusetts General Hospital |
2013-08-16 | PHASE2 |
| NCT00780494 | COMPLETED | Stomach Cancer; Gastric (Stomach) Cancer; Neoplasm of Cardioesophageal Junction; Gastrointestinal Stromal Tumor (GIST) |
Stanford University |
2009-02 | PHASE2 |
| NCT03427359 | COMPLETED | Nasopharyngeal Carcinoma |
The University of Hong Kong-Shenzhen Hospital |
2015-01-22 | PHASE2 |
| NCT00450203 | UNKNOWN | Oesophagogastric Cancer |
Professor David Cunningham |
2007-10 | PHASE2; PHASE3 |
| NCT02604615 | UNKNOWN | Stage III Esophageal Squamous Cell Carcinoma; Esophageal Neoplasms |
The First Affiliated Hospital of Henan University of Science and Technology |
2014-10 | PHASE3 |
| NCT01412294 | UNKNOWN | Gastric Cancer |
Epidemiological and Clinical Research Information Network |
2011-07 | PHASE2 |
| NCT02393755 | COMPLETED | Colon Adenocarcinoma; Rectal Adenocarcinoma; Recurrent Colon Carcinoma; Recurrent Rectal Carcinoma; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer |
Roswell Park Cancer Institute |
2015-05-08 | PHASE1; PHASE2 |
| NCT01952951 | UNKNOWN | Rectal Neoplasms; Adenocarcinoma |
National Cancer Center, Korea |
2014-06 | PHASE2 |
| NCT02119026 | COMPLETED | Metastatic Colorectal Cancer |
Prof. Dr. Werner Scheithauer |
2011-02 | PHASE2 |
| NCT01953003 | COMPLETED | Malignant Neoplasm of Breast |
Pierre Fabre Medicament |
2013-09 | PHASE3 |
| NCT02947061 | UNKNOWN | Breast Cancer Recurrent |
Chinese Academy of Medical Sciences |
2015-04 | PHASE2 |
| NCT01876927 | COMPLETED | Gastric Cancer; Locally Advanced Malignant Neoplasm |
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS |
2010-09 | PHASE2 |
| NCT02273713 | COMPLETED | Esophageal Cancer; Toxicity |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2014-10 | PHASE1; PHASE2 |
| NCT00647530 | UNKNOWN | Colorectal Cancer |
University of Birmingham |
2008-05-15 | PHASE2; PHASE3 |
| NCT02038621 | UNKNOWN | Advanced Gastric Cancer |
The Second People's Hospital of Sichuan |
2014-01 | PHASE2 |
| NCT02213744 | TERMINATED | Breast Cancer; HER2 Positive Breast Cancer |
Merrimack Pharmaceuticals |
2014-07 | PHASE2; PHASE3 |
| NCT02207335 | UNKNOWN | Metastatic Breast Cancer |
Tianjin Medical University Cancer Institute and Hospital |
2013-12 | PHASE3 |
| NCT02068131 | UNKNOWN | Metastatic Colorectal Cancer |
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences |
2014-02 | PHASE2 |
| NCT03428529 | COMPLETED | Rectal Neoplasm Malignant |
Instituto Nacional de Cancer, Brazil |
2011-01-12 | PHASE2; PHASE3 |
| NCT02210364 | COMPLETED | Metastatic Breast Cancer; Pancreatic Cancer; Metastatic Colorectal Cancer |
PharmaMar |
2013-04 | PHASE1 |
| NCT02422199 | UNKNOWN | HER2 Positive Metastatic Breast Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2015-05 | PHASE1; PHASE2 |
| NCT02361112 | COMPLETED | Metastatic Breast Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2014-08 | PHASE1 |
| NCT01836432 | TERMINATED | Pancreatic Cancer; Pancreatic Carcinoma Non-resectable; Locally Advanced Malignant Neoplasm |
NewLink Genetics Corporation |
2013-05 | PHASE3 |
| NCT01589159 | COMPLETED | Metastatic Breast Cancer |
Tao OUYANG |
2013-01 | PHASE2 |
| NCT01661972 | COMPLETED | Metastatic Colorectal Cancer |
John Strickler, M.D. |
2012-08 | PHASE1; PHASE2 |
| NCT02403544 | UNKNOWN | Carcinoma, Hepatocellular |
Chinese Academy of Medical Sciences |
2013-09 | PHASE1 |
| NCT02243007 | TERMINATED | Resectable Pancreatic Cancer; Pancreatic Ductal Carcinoma |
Massachusetts General Hospital |
2014-09 | PHASE2 |
| NCT01843452 | TERMINATED | Carcinoma of Anal Canal |
Centre Hospitalier Universitaire Vaudois |
2012-12 | PHASE2 |
| NCT01492101 | COMPLETED | Locally Recurrent Breast Cancer; Metastatic Breast Cancer |
Nektar Therapeutics |
2011-12 | PHASE3 |
| NCT01765582 | TERMINATED | Colorectal Neoplasms |
Hoffmann-La Roche |
2013-01-23 | PHASE2 |
| NCT01206049 | COMPLETED | Cholangiocarcinoma |
Vejle Hospital |
2010-09 | PHASE2 |
| NCT01705106 | TERMINATED | Unspecified Adult Solid Tumor, Protocol Specific |
University of Chicago |
2012-08-29 | PHASE1 |
| NCT02119663 | TERMINATED | Pancreatic Cancer |
Incyte Corporation |
2014-06 | PHASE3 |
| NCT02117479 | TERMINATED | Pancreatic Cancer |
Incyte Corporation |
2014-03 | PHASE3 |
| NCT02043821 | UNKNOWN | Metastatic Colorectal Cancer |
Beijing Chao Yang Hospital |
||
| NCT01130701 | WITHDRAWN | Pancreatic Cancer |
University of Massachusetts, Worcester |
2010-05 | PHASE2 |
| NCT01918852 | COMPLETED | Colorectal Cancer; Metastases |
Dutch Colorectal Cancer Group |
2013-12 | PHASE3 |
| NCT01887288 | TERMINATED | Metastatic Breast Cancer |
Western Regional Medical Center |
2013-04 | PHASE2 |
| NCT01641458 | COMPLETED | Colorectal Cancer |
Cantonal Hospital of St. Gallen |
2012-10 | PHASE4 |
| NCT01928680 | UNKNOWN | Metastatic Breast Cancer |
Chinese Academy of Medical Sciences |
2012-11 | PHASE2 |
| NCT01722162 | COMPLETED | Colorectal Neoplasms |
Washington University School of Medicine |
2013-04 | PHASE2 |
| NCT00997685 | UNKNOWN | Potentially Resectable Liver Metastasis From CRC; Colorectal Cancer |
Guangdong Provincial People's Hospital |
2009-11 | PHASE2 |
| NCT01677988 | TERMINATED | Adenocarcinoma of Head of Pancreas |
Medical University of South Carolina |
2012-07 | PHASE2 |
| NCT01871363 | UNKNOWN | Locally Advanced Malignant Neoplasm |
Chinese Academy of Medical Sciences |
2012-10 | PHASE2 |
| NCT01044433 | COMPLETED | Head and Neck Cancer; Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma; Recurrent Metastatic Squamous Neck Cancer With Occult Primary; Recurrent Salivary Gland Cancer; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Squamous Cell Carcinoma of the Oropharynx; Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Recurrent Verrucous Carcinoma of the Larynx; Recurrent Verrucous Carcinoma of the Oral Cavity; Salivary Gland Squamous Cell Carcinoma; Stage IV Salivary Gland Cancer; Stage IV Squamous Cell Carcinoma of the Hypopharynx; Stage IV Squamous Cell Carcinoma of the Larynx; Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IV Squamous Cell Carcinoma of the Oropharynx; Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IV Verrucous Carcinoma of the Larynx; Stage IV Verrucous Carcinoma of the Oral Cavity |
Abramson Cancer Center at Penn Medicine |
2009-10 | PHASE2 |
| NCT01332604 | COMPLETED | Solid Cancers |
Genentech, Inc. |
2011-07 | PHASE1 |
| NCT01303029 | COMPLETED | Metastatic Pancreatic Cancer |
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) |
2011-02 | PHASE2 |
| NCT01007552 | COMPLETED | Cholangiocarcinoma |
Roswell Park Cancer Institute |
2009-12 | PHASE2 |
| NCT01843829 | UNKNOWN | Oesophageal Cancer |
Lisette Nixon |
2013-10 | PHASE2 |
| NCT01554969 | COMPLETED | Rectal Cancer |
Emory University |
2012-05 | PHASE1 |
| NCT02297230 | TERMINATED | Breast Cancer |
NYU Langone Health |
2002-06 | PHASE1; PHASE2 |
| NCT01962376 | UNKNOWN | Gastric Cancer; Liver Metastasis |
Hebei Medical University |
2013-02 | PHASE4 |
| NCT01050426 | TERMINATED | Pancreatic Cancer |
Royal Marsden NHS Foundation Trust |
2009-03 | PHASE2 |
| NCT01781403 | COMPLETED | Rectal Cancer |
Asan Medical Center |
2013-05-10 | PHASE1 |
| NCT01754623 | TERMINATED | Pancreatic Cancer |
H. Lee Moffitt Cancer Center and Research Institute |
2013-02 | PHASE2 |
| NCT00486213 | TERMINATED | Dermatologic Complications; Palmar-plantar Erythrodysesthesia; Unspecified Adult Solid Tumor, Protocol Specific |
National Cancer Centre, Singapore |
2007-06 | PHASE3 |
| NCT01640665 | COMPLETED | Metastatic Breast Cancer; Gastrointestinal Tumors |
Yale University |
2012-07 | PHASE1 |
| NCT01323530 | COMPLETED | Metastatic Breast Cancer |
Eisai Limited |
2010-01-26 | PHASE1; PHASE2 |
| NCT01238029 | TERMINATED | Metastatic Breast Cancer; HER2 Positive; First or Second Line Therapy; Failure or Contraindication of Trastuzumab Therapy |
Sponsor GmbH |
2010-10 | PHASE1 |
| NCT01969032 | COMPLETED | Triple Negative Breast Cancer |
Russian Academy of Medical Sciences |
2011-08 | PHASE2 |
| NCT01823679 | TERMINATED | Squamous Cell Carcinoma of the Skin; Recurrent Skin Cancer |
Stanford University |
2013-03 | PHASE2 |
| NCT01067989 | TERMINATED | Chemotherapy; Breast Cancer, Metastatic |
HaEmek Medical Center, Israel |
2010-03 | PHASE2 |
| NCT00751101 | TERMINATED | Breast Cancer; Chemotherapeutic Agent Toxicity; Palmar-plantar Erythrodysesthesia |
University of California, San Francisco |
2007-08-20 | PHASE2 |
| NCT00868634 | COMPLETED | Metastatic Breast Cancer |
iOMEDICO AG |
2009-02 | PHASE3 |
| NCT01668680 | TERMINATED | Colorectal Cancer Metastatic |
HaEmek Medical Center, Israel |
2012-09 | PHASE2 |
| NCT00543842 | COMPLETED | Rectal Cancer |
M.D. Anderson Cancer Center |
2007-12 | PHASE1 |
| NCT00114231 | COMPLETED | Colorectal Cancer |
Alliance for Clinical Trials in Oncology |
2006-05 | PHASE2 |
| NCT00925769 | COMPLETED | Pancreatic Cancer |
Hoffmann-La Roche |
2009-01 | PHASE1 |
| NCT01963702 | UNKNOWN | Gastric Cancer |
Fudan University |
2012-08 | PHASE2 |
| NCT01298401 | COMPLETED | Pancreatic Cancer |
Radiation Therapy Oncology Group |
2012-02 | PHASE1 |
| NCT01348009 | UNKNOWN | Gastric Carcinoma |
Genta Incorporated |
2011-05 | PHASE1; PHASE2 |
| NCT01234402 | COMPLETED | Breast Cancer |
Eli Lilly and Company |
2011-03 | PHASE2 |
| NCT00321685 | COMPLETED | Rectal Adenocarcinoma; Stage II Rectal Cancer AJCC v7; Stage III Rectal Cancer AJCC v7 |
National Cancer Institute (NCI) |
2006-07-25 | PHASE2 |
| NCT01316406 | COMPLETED | Palmar-Plantar Erythrodysesthesia Syndrome |
Advancell - Advanced In Vitro Cell Technologies, S.A. |
2011-02 | PHASE2 |
| NCT01438450 | UNKNOWN | Hepatocellular Carcinoma |
All India Institute of Medical Sciences |
2007-10 | PHASE2; PHASE3 |
| NCT01549795 | UNKNOWN | Hilar Cholangiocarcinoma; Primary Sclerosing Cholangitis |
Azienda Ospedaliera di Padova |
2012-01 | |
| NCT01380808 | COMPLETED | Metastatic Breast Cancer |
Fudan University |
2011-05 | PHASE2 |
| NCT01846650 | COMPLETED | Metastatic Breast Cancer or Metastatic Colorectal Cancer |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2012-12 | PHASE1 |
| NCT01322152 | COMPLETED | Colorectal Cancer |
Fudan University |
2011-03 | PHASE2 |
| NCT01415336 | UNKNOWN | Breast Cancer |
Peking Union Medical College Hospital |
2010-03 | PHASE2; PHASE3 |
| NCT00183898 | COMPLETED | Gastric Cancer; Esophageal Cancer |
University of Southern California |
2004-12-28 | PHASE2 |
| NCT00634725 | COMPLETED | Pancreatic Cancer |
GERCOR - Multidisciplinary Oncology Cooperative Group |
2008-02 | PHASE3 |
| NCT01468389 | UNKNOWN | Gastric Cancer |
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences |
2011-11 | PHASE3 |
| NCT00891878 | COMPLETED | Adenocarcinoma of the Gastroesophageal Junction; Esophageal Cancer |
Alliance for Clinical Trials in Oncology |
2009-08 | PHASE2 |
| NCT02071043 | COMPLETED | Advanced Gastric Cancer |
Shanghai Zhongshan Hospital |
2008-11 | PHASE2 |
| NCT00849550 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific; Cancer |
Herbert Hurwitz |
2009-07 | PHASE1 |
| NCT00201825 | COMPLETED | Lung Cancer; Non-Small-Cell Lung Carcinoma |
Tony Bekaii-Saab |
2004-12 | PHASE2 |
| NCT01290718 | TERMINATED | Breast Cancer |
Hoffmann-La Roche |
2011-12 | PHASE2 |
| NCT02560974 | COMPLETED | Gastric Cancer |
Hoffmann-La Roche |
2006-06 | PHASE3 |
| NCT00398320 | COMPLETED | Neuroendocrine Tumors |
Pamela L. Kunz |
2006-11 | PHASE2 |
| NCT01161186 | COMPLETED | Pancreatic Neoplasms; Pancreatic Cancer; Adenocarcinoma |
University of California, San Francisco |
2010-07 | PHASE1 |
| NCT01609166 | COMPLETED | Hand-foot Syndrome |
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
2011-07 | PHASE2 |
| NCT00444678 | COMPLETED | Colorectal Cancer; Neoplasm Metastasis |
NYU Langone Health |
2004-06-01 | PHASE2 |
| NCT01158274 | COMPLETED | Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; HER2-negative Breast Cancer; HIV-associated Hodgkin Lymphoma; Intraocular Lymphoma; Male Breast Cancer; Nodal Marginal Zone B-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Primary Central Nervous System Hodgkin Lymphoma; Primary Central Nervous System Non-Hodgkin Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Breast Cancer; Recurrent Colon Cancer; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Rectal Cancer; Recurrent Small Lymphocytic Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Colon Cancer; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Rectal Cancer; Stage III Small Lymphocytic Lymphoma; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Breast Cancer; Stage IV Colon Cancer; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Rectal Cancer; Stage IV Small Lymphocytic Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific; Waldenström Macroglobulinemia |
National Cancer Institute (NCI) |
2010-06 | PHASE1 |
| NCT00854477 | COMPLETED | Pancreatic Adenocarcinoma |
Cambridge University Hospitals NHS Foundation Trust |
2009-11 | PHASE4 |
| NCT00964457 | UNKNOWN | Rectum Cancer |
Copenhagen University Hospital at Herlev |
2009-08 | PHASE2 |
| NCT00561522 | UNKNOWN | Hepatocellular Carcinoma; Neoplasm Metastasis |
Fudan University |
2007-11 | PHASE2; PHASE3 |
| NCT00967655 | UNKNOWN | Colorectal Cancer |
Loma Linda Oncology Medical Group, Inc. |
2009-07 | PHASE2 |
| NCT00820222 | COMPLETED | Metastases, Brain |
Novartis Pharmaceuticals |
2009-04-14 | PHASE3 |
| NCT01471847 | COMPLETED | Locally Advance Breast Cancer (LABC); Metastatic Breast Cancer (MBC) |
Novartis Pharmaceuticals |
2012-02 | PHASE1 |
| NCT00777478 | UNKNOWN | Colorectal Cancer |
Radboud University Medical Center |
2008-12 | PHASE1 |
| NCT01151761 | TERMINATED | Cholangiocarcinoma; Hepatobiliary Neoplasm; Liver Cancer; Bile Duct Cancer; Cancer of Gallbladder |
Stanford University |
2011-01 | PHASE2 |
| NCT00677144 | COMPLETED | Colorectal Neoplasm |
Hallym University Medical Center |
2008-04 | PHASE2 |
| NCT00462865 | TERMINATED | Breast Cancer |
Brown University |
2007-11 | PHASE2 |
| NCT00418028 | COMPLETED | Metastatic Breast Cancer |
Hospital San Carlos, Madrid |
2005-09 | PHASE2; PHASE3 |
| NCT00473005 | TERMINATED | Breast Cancer |
Stanford University |
2007-08 | PHASE1 |
| NCT00585078 | COMPLETED | Pancreatic Cancer |
Beth Israel Deaconess Medical Center |
2004-05 | PHASE2 |
| NCT00615940 | COMPLETED | Metastatic Breast Cancer |
Heidelberg Pharma AG |
2008-07 | PHASE2 |
| NCT00514293 | UNKNOWN | Lung Cancer |
Raghu Nandan, M.D., Inc |
2007-01 | PHASE2 |
| NCT01095003 | COMPLETED | Breast Cancer |
Pierre Fabre Medicament |
2009-05 | PHASE3 |
| NCT00700570 | COMPLETED | Colorectal Cancer |
Hoffmann-La Roche |
2008-08 | PHASE2 |
| NCT00952497 | COMPLETED | Gastric Cancer |
ACT Biotech, Inc |
2009-06 | PHASE2 |
| NCT00976976 | COMPLETED | Resected Advanced Gastric Cancer |
Asan Medical Center |
2007-05 | PHASE2 |
| NCT00534417 | COMPLETED | Metastatic Breast Cancer |
Accelerated Community Oncology Research Network |
2007-10 | PHASE2 |
| NCT00601627 | COMPLETED | Pancreatic Cancer |
Alliance for Clinical Trials in Oncology |
2009-06 | PHASE2 |
| NCT01049620 | COMPLETED | Advanced Gastric Cancer |
Asan Medical Center |
2010-02 | PHASE1 |
| NCT00483834 | COMPLETED | Colorectal Cancer |
University Health Network, Toronto |
2006-12 | PHASE2 |
| NCT01128842 | COMPLETED | Advanced Malignant Solid Tumors |
Puma Biotechnology, Inc. |
2010-04 | PHASE1 |
| NCT01077726 | COMPLETED | Breast Cancer |
Hoffmann-La Roche |
2010-01 | PHASE2 |
| NCT00398879 | COMPLETED | Colon Cancer |
AEterna Zentaris |
2005-08 | PHASE2 |
| NCT00477464 | COMPLETED | Metastatic Breast Cancer; Neoplasms, Breast |
GlaxoSmithKline |
2007-06 | PHASE2 |
| NCT00719550 | COMPLETED | Esophagogastric Junction Adenocarcinoma; Gastric Cancer; Esophageal Cancer |
Amgen |
2009-02 | PHASE1; PHASE2 |
| NCT01067053 | UNKNOWN | Metastatic Colorectal Cancer |
Grupo Espanol Multidisciplinario del Cancer Digestivo |
2009-11 | PHASE2 |
| NCT00436241 | COMPLETED | Gastric Cancer |
Hoffmann-La Roche |
2007-03 | PHASE2 |
| NCT02563054 | COMPLETED | Gastric Cancer |
Hoffmann-La Roche |
2003-04 | PHASE3 |
| NCT00504660 | COMPLETED | Anaplastic Glioma of Brain; Glioblastoma Multiforme; Brain Cancer |
M.D. Anderson Cancer Center |
2003-09 | PHASE2 |
| NCT00074321 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2003-11 | PHASE1 |
| NCT00112918 | COMPLETED | Colorectal Cancer |
Hoffmann-La Roche |
2004-12 | PHASE3 |
| NCT00816868 | COMPLETED | Non-small Cell Lung Cancer |
Sun Yat-sen University |
2009-01 | PHASE2 |
| NCT01079702 | UNKNOWN | Advanced Malignancies |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2008-04 | PHASE1; PHASE2 |
| NCT00842491 | COMPLETED | Advanced Gastric Cancer |
Peking University |
2008-11 | PHASE2 |
| NCT00399035 | COMPLETED | Metastatic Colorectal Cancer |
AstraZeneca |
2006-11 | PHASE3 |
| NCT00833859 | TERMINATED | Pancreatic Neoplasms |
H. Lee Moffitt Cancer Center and Research Institute |
2009-03 | PHASE2 |
| NCT00077857 | COMPLETED | Breast Cancer |
Hoffmann-La Roche |
2003-07 | PHASE2 |
| NCT00068588 | COMPLETED | Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer |
National Cancer Institute (NCI) |
2003-10 | PHASE2 |
| NCT00568022 | COMPLETED | Breast Cancer |
R-Pharm |
2008-02 | PHASE1 |
| NCT01869192 | COMPLETED | Malignant Neoplasm of Female Breast |
University of Colorado, Denver |
2003-03-05 | PHASE2 |
| NCT00602082 | COMPLETED | Gastrointestinal Carcinoid Tumor; Islet Cell Tumor |
Cambridge University Hospitals NHS Foundation Trust |
2005-08 | PHASE2 |
| NCT00842244 | COMPLETED | Stomach Neoplasms; Advanced Gastric Cancer |
Pfizer |
2009-04 | PHASE1 |
| NCT00662025 | COMPLETED | Advanced/Metastatic Breast Cancer |
Pfizer |
2008-04 | PHASE2 |
| NCT00354887 | COMPLETED | Gastrointestinal Cancer |
M.D. Anderson Cancer Center |
2004-11 | PHASE2 |
| NCT00548548 | COMPLETED | Adenocarcinoma |
Genentech, Inc. |
2007-09 | PHASE3 |
| NCT00373113 | TERMINATED | Breast Neoplasms |
Pfizer |
2006-11 | PHASE3 |
| NCT00743964 | COMPLETED | Advanced Gastric Cancer |
Samsung Medical Center |
2008-04 | PHASE2 |
| NCT00266279 | COMPLETED | Head or Neck Cancer |
University of Louisville |
2005-04 | PHASE2 |
| NCT00296062 | TERMINATED | Colorectal Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
Case Comprehensive Cancer Center |
2006-03 | PHASE1 |
| NCT00827580 | TERMINATED | Breast Cancer; Colon Cancer |
West Virginia University |
2009-01 | PHASE1 |
| NCT00574171 | COMPLETED | Metastatic Colorectal Cancer |
University of Wisconsin, Madison |
2007-09 | PHASE2 |
| NCT00121277 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
University Health Network, Toronto |
2005-09 | PHASE1 |
| NCT00209092 | COMPLETED | Breast Cancer |
Emory University |
2006-08 | PHASE2 |
| NCT00130507 | TERMINATED | Breast Cancer |
Spanish Breast Cancer Research Group |
2005-11-04 | PHASE2 |
| NCT00568529 | SUSPENDED | Gastric Cancer |
Fudan University |
2007-10 | PHASE2 |
| NCT00960284 | COMPLETED | Pancreatic Cancer |
IRCCS San Raffaele |
2003-06 | PHASE2; PHASE3 |
| NCT00711412 | COMPLETED | Esophageal Cancer |
Northwestern University |
2006-05-31 | PHASE2 |
| NCT00182715 | UNKNOWN | Colorectal Cancer |
Velindre NHS Trust |
2005-03 | PHASE3 |
| NCT00338988 | COMPLETED | Cancer of the Gallbladder; Cancer of the Biliary Tract |
M.D. Anderson Cancer Center |
2003-08 | PHASE2 |
| NCT00689702 | UNKNOWN | Rectal Cancer |
Institute of Oncology Ljubljana |
2007-02 | PHASE2 |
| NCT01186081 | COMPLETED | Rectal Cancer |
Asan Medical Center |
2004-03 | PHASE3 |
| NCT00767689 | TERMINATED | Hand and Foot Syndrome |
Cook County Health |
2006-03-21 | |
| NCT00744640 | COMPLETED | Locally Advanced Pancreatic Cancer; Metastatic Pancreatic Cancer |
University Hospital, Basel, Switzerland |
2005-10 | PHASE1; PHASE2 |
| NCT00632489 | COMPLETED | Breast Cancer |
SCRI Development Innovations, LLC |
2008-05 | PHASE1 |
| NCT00431106 | COMPLETED | Breast Cancer |
Hellenic Oncology Research Group |
2002-04 | PHASE3 |
| NCT00290615 | COMPLETED | Colorectal Cancer |
Herbert Hurwitz |
2006-01 | PHASE2 |
| NCT00113230 | COMPLETED | Rectal Cancer |
M.D. Anderson Cancer Center |
2005-02 | PHASE2 |
| NCT00093808 | COMPLETED | Breast Cancer |
Alliance for Clinical Trials in Oncology |
2004-08 | PHASE2 |
| NCT00191152 | COMPLETED | Breast Cancer; Breast Neoplasms; Cancer of the Breast |
Eli Lilly and Company |
2002-02 | PHASE3 |
| NCT00536809 | COMPLETED | Neoplasms, Colorectal |
GlaxoSmithKline |
2007-09-26 | PHASE1 |
| NCT00227747 | COMPLETED | Colorectal Cancer |
UNICANCER |
2005-11-08 | PHASE3 |
| NCT00345696 | COMPLETED | Metastatic Colorectal Cancer |
Unidad Integral de Investigación en Oncología S.L. |
2006-06 | PHASE2 |
| NCT00084617 | COMPLETED | Adenocarcinoma of the Gastroesophageal Junction; Diffuse Adenocarcinoma of the Stomach; Intestinal Adenocarcinoma of the Stomach; Mixed Adenocarcinoma of the Stomach; Recurrent Gastric Cancer; Stage IIIA Gastric Cancer; Stage IIIB Gastric Cancer; Stage IIIC Gastric Cancer; Stage IV Gastric Cancer |
National Cancer Institute (NCI) |
2004-03 | PHASE2 |
| NCT00320749 | COMPLETED | Pancreatic Cancer |
Tony Bekaii-Saab |
2005-12 | PHASE1 |
| NCT00345761 | COMPLETED | Colorectal Cancer |
Chugai Pharmaceutical |
2006-02 | PHASE1; PHASE2 |
| NCT00398398 | COMPLETED | Gastric Cancer |
Asan Medical Center |
2006-11 | PHASE2 |
| NCT00290693 | COMPLETED | Pancreatic Cancer |
University of Miami |
2004-07 | PHASE2 |
| NCT00100815 | COMPLETED | Pancreatic Cancer |
Roswell Park Cancer Institute |
2004-08 | PHASE2 |
| NCT00215644 | COMPLETED | Esophageal Cancer; Gastric Cancer |
Merck KGaA, Darmstadt, Germany |
2005-08-31 | PHASE2 |
| NCT00423696 | COMPLETED | Colorectal Cancer |
UNICANCER |
2006-03-23 | PHASE2 |
| NCT00618124 | COMPLETED | Solid Tumors; Breast Cancer; Neoplasms |
Pfizer |
2005-05 | PHASE1 |
| NCT00305877 | COMPLETED | Stage IA Pancreatic Cancer; Stage IB Pancreatic Cancer; Stage IIA Pancreatic Cancer; Stage IIB Pancreatic Cancer |
National Cancer Institute (NCI) |
2006-02 | PHASE2 |
| NCT00107315 | TERMINATED | Colorectal Cancer |
Roswell Park Cancer Institute |
2004-07 | PHASE2 |
| NCT00345059 | TERMINATED | Advanced Non-Small Cell Lung Cancer |
National Cancer Institute, Naples |
2005-05 | PHASE3 |
| NCT00354601 | TERMINATED | Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer |
Wake Forest University Health Sciences |
2006-01 | PHASE2 |
| NCT00496301 | COMPLETED | Carcinoma, Renal Cell |
Spanish Oncology Genito-Urinary Group |
2006-11 | PHASE2 |
| NCT00084643 | COMPLETED | Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IIIC Colon Cancer; Stage IIIC Rectal Cancer; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2004-05 | PHASE1 |
| NCT00372944 | COMPLETED | Pancreatic Cancer |
AstraZeneca |
2006-08 | PHASE2 |
| NCT02005549 | COMPLETED | Breast Cancer |
Hoffmann-La Roche |
2006-02 | PHASE2 |
| NCT00365417 | COMPLETED | Breast Cancer |
NSABP Foundation Inc |
2006-08 | PHASE2 |
| NCT00544765 | COMPLETED | Breast Cancer |
GBG Forschungs GmbH |
2002-09 | PHASE3 |
| NCT00291486 | COMPLETED | Colorectal Neoplasms |
Ludwig Institute for Cancer Research |
2003-10 | PHASE1 |
| NCT00416494 | COMPLETED | Colorectal Cancer |
Herbert Hurwitz, MD |
2003-09 | PHASE2 |
| NCT00258284 | COMPLETED | Prostate Cancer |
Barbara Ann Karmanos Cancer Institute |
2003-08 | PHASE2 |
| NCT00303927 | COMPLETED | Pancreatic Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-12 | PHASE2 |
| NCT00010023 | COMPLETED | Cancer |
NYU Langone Health |
2000-08 | PHASE1 |
| NCT00016926 | COMPLETED | Cervical Cancer |
Gynecologic Oncology Group |
2001-04 | PHASE2 |
| NCT00281788 | COMPLETED | Esophageal Cancer |
Duke University |
2003-09 | PHASE1 |
| NCT00049335 | COMPLETED | Colorectal Cancer |
SWOG Cancer Research Network |
2003-02 | PHASE2 |
| NCT00216021 | COMPLETED | Metastatic Breast Cancer |
Hoosier Cancer Research Network |
2004-03 | PHASE2 |
| NCT00311467 | TERMINATED | Renal Cell Cancer |
Central European Cooperative Oncology Group |
2004-03 | PHASE3 |
| NCT00118105 | WITHDRAWN | Colorectal Cancer; Metastatic Cancer |
SWOG Cancer Research Network |
2006-11 | PHASE2 |
| NCT00268151 | TERMINATED | Carcinoma, Non-Small Cell Lung |
University of Louisville |
2005-02 | PHASE1 |
| NCT00077363 | COMPLETED | Recurrent Breast Cancer; Stage IV Breast Cancer |
National Cancer Institute (NCI) |
2004-05 | PHASE2 |
| NCT00278863 | COMPLETED | Gastric Cancer |
Asan Medical Center |
2004-11 | PHASE2 |
| NCT00080301 | COMPLETED | Breast Cancer; Metastases |
R-Pharm |
2003-09 | PHASE3 |
| NCT00354523 | TERMINATED | Solid Tumor; Thyroid Cancer |
M.D. Anderson Cancer Center |
2004-12 | PHASE1; PHASE2 |
| NCT02694718 | COMPLETED | Rectal Cancer |
Hoffmann-La Roche |
2005-03 | PHASE2 |
| NCT00047710 | COMPLETED | Pancreatic Cancer |
M.D. Anderson Cancer Center |
2002-09 | PHASE1 |
| NCT00159471 | TERMINATED | Pancreatic Cancer |
University of Southern California |
2005-02 | |
| NCT02567331 | COMPLETED | Colorectal Cancer |
Hoffmann-La Roche |
2004-10 | PHASE4 |
| NCT02748213 | COMPLETED | Breast Cancer |
Hoffmann-La Roche |
2002-02 | PHASE2 |
| NCT00207129 | COMPLETED | Advanced Solid Tumors; Neoplasms |
R-Pharm |
2004-10 | PHASE1 |
| NCT00165217 | COMPLETED | Colorectal Adenocarcinoma |
Dana-Farber Cancer Institute |
2001-11 | PHASE2 |
| NCT00227734 | COMPLETED | Colorectal Cancer |
Swiss Cancer Institute |
2004-06 | PHASE2 |
| NCT00006812 | TERMINATED | Ovarian Cancer; Primary Peritoneal Cavity Cancer |
Gynecologic Oncology Group |
2001-03 | PHASE2 |
| NCT00048139 | COMPLETED | Colorectal Cancer |
Hoffmann-La Roche |
2001-10 | PHASE2 |
| NCT00193102 | TERMINATED | Breast Cancer |
SCRI Development Innovations, LLC |
2001-04 | PHASE2 |
| NCT00048126 | COMPLETED | Colorectal Cancer |
Hoffmann-La Roche |
2001-07 | PHASE2 |
| NCT00022698 | COMPLETED | Colorectal Cancer |
Hoffmann-La Roche |
2001-05 | PHASE2 |
| NCT00003902 | COMPLETED | Breast Cancer |
Swiss Cancer Institute |
1999-03 | PHASE1; PHASE2 |
| NCT00070265 | TERMINATED | Liver Metastases; Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IV Colon Cancer; Stage IV Rectal Cancer |
National Cancer Institute (NCI) |
2003-08 | PHASE2 |
| NCT00084942 | COMPLETED | Extrahepatic Bile Duct Cancer; Gallbladder Cancer |
Roswell Park Cancer Institute |
2002-10 | PHASE2 |
| NCT00004187 | COMPLETED | Colorectal Cancer |
Swiss Cancer Institute |
1999-06 | PHASE1; PHASE2 |
| NCT00006465 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Case Comprehensive Cancer Center |
2000-12 | PHASE1 |
| NCT00324610 | UNKNOWN | Breast Neoplasms; Chemotherapy |
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie |
2006-03 | PHASE1; PHASE2 |
| NCT00032175 | COMPLETED | Pancreatic Cancer |
Cancer Research UK |
2002-04 | PHASE3 |
| NCT00095641 | WITHDRAWN | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Oropharynx |
SWOG Cancer Research Network |
PHASE2 | |
| NCT00288002 | COMPLETED | Breast Cancer |
GBG Forschungs GmbH |
2005-01 | PHASE3 |
| NCT00075556 | UNKNOWN | Colorectal Cancer |
GERCOR - Multidisciplinary Oncology Cooperative Group |
2002-01 | PHASE2 |
| NCT00212589 | COMPLETED | Colorectal Cancer |
Odense University Hospital |
2002-12 | PHASE3 |
| NCT00506168 | TERMINATED | Colorectal Neoplasms; Secondary; Drug Therapy, Combination |
National Cancer Center, Korea |
2001-11 | PHASE2 |
| NCT00226798 | UNKNOWN | Adenocarcinoma Clear Cell |
Rambam Health Care Campus |
2003-12 | PHASE2 |
| NCT00675194 | COMPLETED | Gastric Cancer |
Johannes Gutenberg University Mainz |
2003-10 | PHASE2 |
| NCT00303745 | UNKNOWN | Colorectal Cancer |
Federation Francophone de Cancerologie Digestive |
2006-06 | PHASE2 |
| NCT00220129 | COMPLETED | Oesophageal Carcinoma |
Royal Marsden NHS Foundation Trust |
2002-11 | PHASE2 |
| NCT00220168 | COMPLETED | Upper Gastrointestinal Tumours |
Royal Marsden NHS Foundation Trust |
2003-01 | PHASE4 |
| NCT00216437 | TERMINATED | Cancer of Liver |
James A. Haley Veterans Administration Hospital |
2004-12 | PHASE1 |
| NCT00109239 | COMPLETED | Breast Cancer |
Genentech, Inc. |
2000-11 | PHASE3 |
(data from https://clinicaltrials.gov, updated on 2025-09-09)
Check the
Capecitabine
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Capecitabine Mechanism of Action: Thymidylate Synthase Inhibition in Breast Cancer Cell Research
- Capecitabine Working Concentration | Cell Culture | Treatment
- Capecitabine Solubility in DMSO
- Capecitabine Stock Solution
- Capecitabine Storage
- Capecitabine Stability
- Capecitabine Combination Database
- Capecitabine Molecular Weight
- Capecitabine SMILES
- Capecitabine CAS Number
- Capecitabine Chemical Structure (2D and 3D)
- Capecitabine IC50 for Cell-based and Cell-free Assays
- Capecitabine Sigma (PHR1405)? Try a better option.
- Capecitabine Cayman (10487)? Try a better option.
- Capecitabine APExBIO (A8647)? Try a better option.
- Capecitabine MedChemExpress (HY-B0016)? Try a better option.
- Capecitabine SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.